Statin therapy in a kindred with both apoliprotein B and low density lipoprotein receptor gene defects

Atherosclerosis

Volumn 129, Issue 1, 1997, Pages 97-102

  Raal, Frederick J ^a   Pilcher, Gillian ^a   Rubinsztein, David C ^b   Lingenhel, Arno ^c   Utermann, Gerd ^c  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

familial defective apo B 100; familial hypercholesterolaemia; lipoprotein(a); statin therapy

Indexed keywords

APOLIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; SIMVASTATIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; GENETIC DISORDER; HUMAN; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

ANIMALS; ANTILIPEMIC AGENTS; APOLIPOPROTEIN B-100; APOLIPOPROTEINS A; APOLIPOPROTEINS B; CATS; CHILD, PRESCHOOL; CHOLESTEROL, LDL; FEMALE; FOLLOW-UP STUDIES; HETEROZYGOTE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; IMMUNOBLOTTING; LOVASTATIN; MALE; MIDDLE AGED; PEDIGREE; PHENOTYPE; RECEPTORS, LDL; SIMVASTATIN; TREATMENT OUTCOME;

EID: 0031056539     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(96)06007-8     Document Type: Article

References (26)

1. Goldstein JL, Brown MS. Familial hypercholesterolaemia. In: Scriver CR, Beaudet AL, Sly WS, Valle, D, (eds). The Metabolic Basis of Inherited Disease, 6th edn. New York: McGraw-Hill, 1989;1215-1250.
2. Hobbs HH, Brown MS, Goldstein JL. Molecular genetics of the LDL receptor gene family in familial hypercholesterolaemia. Hum Mutat 1992;1:445-466.
3. Innerarity TL, Weisgraber KH, Arnold KS et al. Familial defective apolipoprotein B-100: low density lipoproteins with abnormal receptor binding. Proc Natl Acad Sci USA 1987;84:6919-6923.
4. Illingworth DR, Vakar F, Mahley RW, Weisgraber KH. Hypocholesterolaemic effect of lovastatin in familial defective apolipoprotein B-100. Lancet 1992;339:598-600.
5. Maher VMG, Gallagher JJ, Thompson GR, Myant NB. Response to cholesterol-lowering drugs in familial defective apolipoprotein B-100. Atherosclerosis 1991;91:73-76.
6. Defesche JC, Pricker KL, Hayden MR, van der Ende BE, Kastelein JJ. Familial defective apolipoprotein B-100 is clinically indistinguishable from familial hypercholesterolemia. Arch Intern Med 1993;153:2349-2356.
7. Rubinsztein DC, Raal FJ, Seftel HC et al. Characterization of six patients who are double heterozygotes for familial hypercholesterolaemia and familial defective apo B-100. Arterioscler Thromb 1993;13:1076-1081.
8. Deeg R, Ziegenhorn J. Kinetic enzymic method for automated determination of total cholesterol in man. Clin Chem 1983;29:1798-1802.
9. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
10. Menzel HJ, Dieplinger H, Lackner C et al. Abetalipoproteinaemia with an apo B-100 lipoprotein(a) glycoprotein complex in plasma: indication for an assembly defect. J Biol Chem 1990;265:981-986.
11. Kamboh MI, Ferrell RE, Kottke BA. Expressed hypervariable polymorphism of apolipoprotein(a). Am J Hum Genet 1991;49:1063-1074.
12. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hha I. J Lipid Res 1990;31:545-548.
13. Malmendier CL, Lontie JF, Delcroix C, Magot T. Effects of simvastatin on receptor-dependent low-density lipoprotein catabolism in normo-cholesterolaemic human volunteers. Atherosclerosis 1989;80:101-105.
14. Friedl W, Ludwig EH, Balestra ME et al. Apolipoprotein B gene mutations in Austrian subjects with heart disease and their kindred. Arteriosclerosis 1991;11:371-375.
15. Innerarity TL, Balestra ME, Arnold KS et al. Isolation of defective receptor-binding low-density lipoproteins from subjects with familial defective apolipoprotein B-100. Arteriosclerosis 1988;8:551a.
16. Mayer VMG, Gallagher JJ, Myant NB. The binding of very-low-density lipoprotein remnants to the low-density lipoprotein receptor in familial defective apolipoprotein B-100. Atherosclerosis 1993;102:51-61.
17. Gallagher JJ, Myant NB. The affinity of low-density lipoproteins and of very-low-density lipoprotein remnants for the low-density lipoprotein receptor in homozygous familial defective apolipoprotein B-100. Atherosclerosis 1995;115:263-272.
18. Kostner GM, Gavish D, Leopold B et al. HMG CoA reductase inhibitors lower LDL cholesterol without reducing Lp(a) levels. Circulation 1989;80:1313-1319.
19. Leren TP, Hjermann I, Berg K et al. Effects of lovastatin alone and in combination with cholestyramine on serum lipids and apolipoproteins in heterozygotes for familial hypercholesterolaemia. Atherosclerosis 1988;73:135-141.
20. Synder ML, Polacek D, Scanu AM, Fless GM. Comparative binding and degradation of lipoprotein(a) and low density lipoprotein by human monocyte-derived macrophages. J Biol Chem 1992;267:339-346.
21. Hofmann SL, Eaton DL, Brown MS et al. Overexpression of human low density receptors leads to accelerated catabolism of Lp(a) lipoprotein in transgenic mice. J Clin Invest 1990;85:1542-1547.
22. Rader DJ, Mann WA, Cain W et al. The low density lipoprotein receptor is not required for normal catabolism of Lp(a) in humans. J Clin Invest 1995;95:1403-1408.
23. Sandholzer C, Feussner G, Brunzell J, Utermann G. Distribution of apolipoprotein(a) in the plasma from patients with lipoprotein lipase deficiency with type III hyperlipoproteinaemia: no evidence for a triglyceride-rich precursor of lipoprotein(a). J Clin Invest 1992;90:1958-1965.
24. White AL, Lanford RE. Biosynthesis and metabolism of lipoprotein(a). Curr Opin Lipidology 1995;6:75-80.
25. Myant NB. Familial defective apolipoprotein B-100: a review, including some comparisons with familial hypercholesterolaemia. Atherosclerosis 1993;104:1-18.
26. Kraft HG, Köchl S, Menzel HJ, Sandholzer C, Utermann G. The apolipoprotein(a) gene: a transcribed hypervariable locus controlling plasma lipoprotein(a) concentration. Hum Genet 1992;90:220-230.